January 14, 2012
J.K. WallA new report by BioCrossroads says 53 percent of the 20,000 jobs in Indiana’s medical-device sector require no more
than a high school education.
More
January 7, 2012
IBJ StaffNew York-based Epstein Becker Green already has clients here, including Biomet and Roche Diagnostics.
More
December 31, 2011
J.K. WallAfter spending most of 2011 as a Wall Street darling, the year ended ugly for Endocyte Inc. But CEO Ron Ellis thinks the West
Lafayette-based drug developer is in better position than ever.
More
December 27, 2011
J.K. WallIt’s hard to believe now, but as recently as two years ago, Indianapolis was close to losing its 15th-largest employer.
Roche Diagnostics Corp. was looking seriously at moving its 2,900-employee North American headquarters out of Indianapolis.
More
December 21, 2011
Kexue Huang was sentenced after pleading guilty in October to sending Dow AgroSciences trade secrets to China and Germany.
More
December 21, 2011
Scott OlsonFederal prosecutors are recommending that Kexue Huang be sentenced to 87 months in prison for sending trade secrets worth
millions to China and Germany.
More
November 28, 2011
Chris O'MalleyRegulators allege CEO Patrick G. Rooney diverted millions of dollars from a hedge fund into the struggling Fishers company
without investors' knowledge.
More
November 26, 2011
Chris O'MalleyThe office, at NASA Ames Research Center, in Mountain View, Calif., aims to commercialize Purdue-developed technology through
partnerships with private industry.
More
November 26, 2011
Kristin Jones / Special to IBJFor Indiana's life sciences sector, the change both raises hopes and creates challenges for continued growth.
More
November 12, 2011
J.K. WallEndocyte employs 12 people in Indianapolis and plans to add three or four more commercial executives there over the next year
and a half as it anticipates approval of its ovarian cancer medication in Europe.
More
November 7, 2011
J.K. WallThe nation’s shortage of certain drugs is threatening to affect research trials being conducted by Eli Lilly and Co.
and Endocyte Inc.
More
October 31, 2011
J.K. WallThe number of payments in excess of $1 million didn’t change substantially from year to year, but orthopedic companies
sharply cut their fees to surgeons who received the smallest amounts.
More
October 31, 2011
Associated PressHumana Inc. raised its 2011 earnings forecast, following the lead set by other big insurers, including competitor WellPoint
Inc.
More
October 29, 2011
Chris O'MalleyOver the last 12 months, the Indiana Board of Pharmacy has conducted license litigation involving at least 35 pharmacy personnel
statewide who've been accused of stealing drugs from work.
More
October 29, 2011
Katie MaurerRND Group fills development gaps for companies.
More
October 27, 2011
IBJ Staff and Bloomberg NewsIndianapolis-based Dow AgroSciences on Thursday reported record third-quarter sales of $1.2 billion, up 27 percent from the
same period a year ago.
More
October 20, 2011
Chris O'MalleyBioCrossroads’ Indiana Seed Fund has invested $300,000 in a startup company chaired by a former Eli Lilly and Co. executive
developing an absorbable stent.
More
October 20, 2011
J.K. WallThe Indianapolis-based drugmaker earned $1.24 billion in the three months ended Sept. 30, down 5 percent from the same quarter
a year ago, even as revenue surged 9 percent.
More
October 18, 2011
IBJ Staff and Associated PressKexue Huang faces up to 13 years in prison after pleading guilty Tuesday morning to sending trade secrets worth millions to
China and Germany.
More
October 17, 2011
J.K. WallSherry Keramidas, who earned her doctorate in neuroscience and physiological psychology from Purdue University,
is executive director of the Maryland-based Regulatory Affairs Professionals Society, which is holding its annual conference
Oct. 22-26 at the Indiana Convention Center.
More
October 13, 2011
Bloomberg NewsThe device would be the first drug-coated stent approved in the U.S. to treat peripheral vascular disease in the largest artery
of the upper leg.
More
October 11, 2011
Bloomberg NewsPeripheral vascular devices, including stents, angioplasty balloons and synthetic grafts, generated $4.3 billion in global
revenue last year and may earn $5.6 billion in 2014.
More
October 8, 2011
IBJ StaffThe advocate for the state's life sciences industry has now pulled in more than $25 million from the endowment.
More
October 1, 2011
IBJ StaffThe $500,000 gift will help further a decade-long expansion of the school's life sciences curriculum.
More
September 27, 2011
Associated PressA federal judge in Pittsburgh has thrown out a lawsuit filed by a Pittsburgh company that claimed its so-called "Bio
Cremation" service — a flameless process to cremate remains — was being unfairly targeted by two Indiana
competitors.
More
Saw the Indy Men's Chorus "Music of Gilbert & Sullivan" at the Indiana Historical Society on Sunday evening.
Temporary workers are not "tools" they are people and companies that keep large amounts of temp staff are cheating.
I miss having them around. I hope one of their stores is in the general Meridian/86th Street area. I will make good use of it.
The Fringe! Plus, the simple fact that there are so many local faves in such close proximity to each other.
I remenber, watching the toll road, being built, through South Bend, when I was 10 years old. I believe, back then that it was estimated, that the toll road, would be paid for in 20 years and then it would be free. I am now 71, what happened? Since the power is in the people, by that, I mean that, we the people are in total control of everything. I, suggest that no one ever use the toll road again, let it go broke. We the people can control the price of everything, from groceries to gas, if we would just do it. If we don't pay the asking price, the sellers will lower the price and if we wait awhile, they will lower the price to what we accept as reasonable. I would like to know why a highway like interstate 94, is so well maintained, a much better highway, than the toll road, but has no tolls. I would also like to know why, a sitting governor, with a term limit, maximum of eight years, can lease, public property, for 75 years. Even though I have transponders in both of my trucks and will not be affected by the increase, I have been and will contine to avoid using the toll road. I make many trips from northern Indiana to Chicago, every year, and I prefer the better highway, I94!